Provectus and Pfizer Receive Patent Allowance for Experimental Therapy in Combination with Systemic Immunotherapy For Melanoma Treatment
Melanoma, News
Provectus Biopharmaceuticals, Inc. a company specialized in developing oncology and dermatology therapies, recently announced that is has received from the US Patent and Trademark Office a Notice of Allowance for ... Read more